| Product NDC: | 10812-131 | 
| Proprietary Name: | Neutrogena Men Triple Protect Face | 
| Non Proprietary Name: | Ensulizole, Octinoxate, and Oxybenzone | 
| Active Ingredient(s): | 10; 60; 20 mg/mL; mg/mL; mg/mL & nbsp; Ensulizole, Octinoxate, and Oxybenzone | 
| Administration Route(s): | TOPICAL | 
| Dosage Form(s): | LOTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 10812-131 | 
| Labeler Name: | Neutrogena Corporation | 
| Product Type: | HUMAN OTC DRUG | 
| FDA Application Number: | part352 | 
| Marketing Category: | OTC MONOGRAPH NOT FINAL | 
| Start Marketing Date: | 20111201 | 
| Package NDC: | 10812-131-10 | 
| Package Description: | 1 TUBE in 1 CARTON (10812-131-10) > 50 mL in 1 TUBE | 
| NDC Code | 10812-131-10 | 
| Proprietary Name | Neutrogena Men Triple Protect Face | 
| Package Description | 1 TUBE in 1 CARTON (10812-131-10) > 50 mL in 1 TUBE | 
| Product NDC | 10812-131 | 
| Product Type Name | HUMAN OTC DRUG | 
| Non Proprietary Name | Ensulizole, Octinoxate, and Oxybenzone | 
| Dosage Form Name | LOTION | 
| Route Name | TOPICAL | 
| Start Marketing Date | 20111201 | 
| Marketing Category Name | OTC MONOGRAPH NOT FINAL | 
| Labeler Name | Neutrogena Corporation | 
| Substance Name | ENSULIZOLE; OCTINOXATE; OXYBENZONE | 
| Strength Number | 10; 60; 20 | 
| Strength Unit | mg/mL; mg/mL; mg/mL | 
| Pharmaceutical Classes |